98%
921
2 minutes
20
Seizures can emerge from multiple or large foci in temporal lobe epilepsy, complicating focally targeted strategies such as surgical resection or the modulation of the activity of specific hippocampal neuronal populations through genetic or optogenetic techniques. Here, we evaluate a strategy in which optogenetic activation of medial septal GABAergic neurons, which provide extensive projections throughout the hippocampus, is used to control seizures. We utilized the chronic intrahippocampal kainate mouse model of temporal lobe epilepsy, which results in spontaneous seizures and as is often the case in human patients, presents with hippocampal sclerosis. Medial septal GABAergic neuron populations were immunohistochemically labelled and were not reduced in epileptic conditions. Genetic labelling with mRuby of medial septal GABAergic neuron synaptic puncta and imaging across the rostral to caudal extent of the hippocampus, also indicated an unchanged number of putative synapses in epilepsy. Furthermore, optogenetic stimulation of medial septal GABAergic neurons consistently modulated oscillations across multiple hippocampal locations in control and epileptic conditions. Finally, wireless optogenetic stimulation of medial septal GABAergic neurons, upon electrographic detection of spontaneous hippocampal seizures, resulted in reduced seizure durations. We propose medial septal GABAergic neurons as a novel target for optogenetic control of seizures in temporal lobe epilepsy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219369 | PMC |
http://dx.doi.org/10.1093/brain/awab042 | DOI Listing |
Br J Pharmacol
September 2025
Department of Pharmacology, College of Pharmacy, China Pharmaceutical University, Nanjing, China.
Background And Purpose: The pathological role of the bile acid receptor TGR5/GPBA in Alzheimer's disease (AD) is not fully understood. We investigated the pharmacological effects and mechanisms of TGR5 in AD model mice.
Experimental Approach: TGR5 expression was assessed in AD mice using immunofluorescence and immunoblotting.
Acta Histochem
September 2025
Division of Neuroanatomy, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1‑1‑1 Minami‑Kogushi, Ube 755‑8505, Japan. Electronic address:
Cholinergic neurons in the basal forebrain cholinergic nuclei (BFCN) and neostriatum (CPu) play key roles in learning, attention, and motor control. The loss of cholinergic neurons causes major neurodegenerative diseases such as Alzheimer's disease. This study aimed to elucidate the molecular diversity of choline acetyltransferase immunoreactive (ChAT-ir) neurons in these brain regions.
View Article and Find Full Text PDFJ Neurosci Methods
September 2025
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia. Electronic address:
Background: Most researchers rely on popular promoters like the synthetic CAG promoter or human synapsin promoter to transduce various brain neurons. However, their effectiveness in transducing forebrain cholinergic neurons remains unclear.
New Method: We compared efficacy of transduction of cholinergic neurons and parvalbumin-positive neurons in the medial septal area of rats and mice by adeno-associated viruses (AAVs) carrying the green fluorescent protein (GFP) marker gene under three distinct promoters-CAG, synapsin, and the mouse choline acetyltransferase (CHAT) promoter.
Turk Neurosurg
May 2025
Istanbul University - Cerrahpasa, Cerrahpasa Medical Faculty.
Aim: The bed nucleus of the stria terminalis (BST), situated deep within the basal forebrain, serves as a key relay in circuits regulating emotion, stress, and autonomic responses. Despite its clinical relevance, particularly in anxiety-related disorders, its detailed white matter connectivity remains underexplored. This study aims to provide an in-depth anatomical description of the BST and its structural affiliations, with an emphasis on its surgical and neuromodulatory relevance.
View Article and Find Full Text PDFBiomolecules
August 2025
Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY 10962, USA.
Down syndrome (DS), stemming from the triplication of human chromosome 21, results in intellectual disability, with early mid-life onset of Alzheimer's disease (AD) pathology. Early interventions to reduce cognitive impairments and neuropathology are lacking. One modality, maternal choline supplementation (MCS), has shown beneficial effects on behavior and gene expression in neurodevelopmental and neurodegenerative disorders, including trisomic mice.
View Article and Find Full Text PDF